Dr. Dan Gallahan is a molecular and cancer biologist with broad expertise in the fields of systems biology, breast cancer, technology development and science policy.  His primary focus is the integration of multiple approaches, tools, and data sets to understanding the complexity of cancer.  As Deputy Director of the Division of Cancer Biology at the National Cancer Institute, he helps lead the Division in its mission of supporting excellence in basic cancer biology research.  He assists in the planning and implementation of the NCI’s overall efforts in genomics, proteomics, structural biology and nanotechnology, and acts as liaison with other government and commercial entities in the areas of technology and systems biology.  In addition, Dr. Gallahan oversees the NCI’s Integrative Cancer Biology Program (ICBP), which is the major effort in systems biology within the NCI.  This program embraces computational modeling as an integral part of cancer understanding and management. 

 

Dr. Gallahan was trained in Molecular Biology and Biochemistry at the University of Maryland, receiving additional post-doctoral training at the NIH and the German Cancer Research Center.  His post-doctoral work included training in proteomics and bioinformatics.  Prior to joining the Division of Cancer Biology, he had an active NCI intramural career within the Laboratory of Tumor Immunology and Biology.  He also had experience outside the government when he served as Director of Molecular Biology and Development for a small bio-tech company.